MYC and melanoma: In melanoma, LCA can activate ERK1/2 signaling, upregulate c-Myc and Cyclin D, and promote tumor cell proliferation, while also impairing dendritic cell maturation and skewing macrophage polarization toward immunosuppressive M2 phenotypes (33, 34).